The use of p63 as an effective immunomarker in the diagnosis of pulmonary squamous cell carcinomas on de-stained bronchial lavage cytological smears

Cytopathology

Volumn 21, Issue 1, 2010, Pages 56-63

  Uke, M ^a   Rekhi, B ^a   Ajit, D ^a   Jambhekar, N A ^a  

^a TATA MEMORIAL HOSPITAL   (India)

Author keywords

Bronchial lavage cytology; Immunocytochemistry; Lung cancer; Non small cell carcinoma; P63; Small cell carcinoma; Squamous cell carcinoma

Indexed keywords

ACETONE; BIOLOGICAL MARKER; METHANOL; PROTEIN P63;

ADULT; AGED; ANTIBODY DETECTION; ARTICLE; CANCER DIAGNOSIS; CONTROLLED STUDY; CYTODIAGNOSIS; CYTOPATHOLOGY; DIAGNOSTIC ACCURACY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PAPANICOLAOU TEST; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENSITIVITY AND SPECIFICITY; TRACHEOBRONCHIAL TOILET;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; BRONCHOALVEOLAR LAVAGE; BRONCHOALVEOLAR LAVAGE FLUID; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; TRANS-ACTIVATORS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEINS;

EID: 74049129432     PISSN: 09565507     EISSN: 13652303     Source Type: Journal    
DOI: 10.1111/j.1365-2303.2009.00678.x     Document Type: Article

References (17)

1. Parkin DH, Whelan SL, Ferlay J, Raymond L, Young J. Cancer Incidence in Five Continents. Vol III, International Agency for Research on Cancer (I.A.R.C). Lyon, France : Scientific publication, 143, I.A.R.C 1997.
2. Notani P. Global variation in cancer incidence and mortality. Curr Sci 2001 81 : 465 474.
3. Travis WD, Brambilla E, Muller-Hermelink HK et al. World Health Organization (WHO) Classification of Tumors: Pathology and Genetics of the Tumors of the Lung, Pleura, Thymus and Heart. Lyon : IARC press 2004 : pp. 26 34.
4. Hansen HH, Pappot H. Primary lung tumors of the lung and pleura. In : Textbook of Medical Oncology. Cavalli F, Hansen HH, Kaye SB (eds). London : Martin Dunitz 1997 : pp. 139 157.
5. Zakowski M. Non-small cell lung cancer in the targeted therapy era. CAP (College of American Pathologists) Today 2007 21 : 93 94.
6. Arora VK, Singh N, Chaturvedi S, Bhatia A. Significance of cytologic criteria in distinguishing small cell from non small cell carcinoma of the lung. Acta Cytol 2003 47 : 216 220.
7. Pelosi G, Pasini F, Stenholm CO et al. P63 immunoreactivity in lung cancer: yet another player in the development of squamous cell carcinomas? J Pathol 2002 198 : 100 109.
8. Wang BY, Gil J, Kaufman D et al. P63 in pulmonary epithelium, pulmonary squamous neoplasms and other pulmonary tumors. Hum Pathol 2002 33 : 921 926.
9. Wu M, Wang B, Gil J et al. p63 and TTF-1 immunostaining: a useful marker for distinguishing small cell carcinoma of lung from poorly differentiated squamous cell carcinoma of lung. Am J Clin Pathol 2003 119 : 696 702.
10. Bedrossian CW, Rybka DL. Bronchial brushing during fiberoptic bronchoscopy for the cytodiagnosis of lung cancers: comparison with sputum and bronchial washings. Acta Cytol 1976 20 : 446 453.
11. Pellegrini G, Dellambra E, Golisano O et al. p63 identifies keratinocyte stem cells. Proc Natl Acad Sci USA 2001 98 : 3156 3161.
12. Di Como CJ, Urist MJ, Babayan I et al. P63 expression profiles in human normal and tumor tissue. Clin Cancer Res 2002 8 : 494 501.
13. Shtilbans V, Szporn A, Wu M, Burstein DE. P63 immunostaining in destained bronchoscopic cytological specimens. Diagn Cytopathol 2005 32 : 198 203.
14. Kalhor N, Zander DS, Liu J. TTF-1 and p63 for distinguishing pulmonary small-cell carcinoma from poorly differentiated squamous cell carcinoma in previously pap-stained cytologic material. Mod Pathol 2006 19 : 1117 1123.
15. Wu M, Szporn AH, Zhang D et al. Cytological applications of p63 and TTF-1 immunostaining in differential diagnosis of lung cancers. Diagn Cytopathol 2005 33 : 223 227.
16. Reis-Filho JS, Albergaria A, Milanezi F, Amendogira I, Schmitt FC. Naked nuclei revisited: p63 immunoexpresssion. Diagn Cytopathol 2002 27 : 135 138.
17. Massion PP, Taflan PM, Jamshedul Rehman SM et al. Significance of p63 amplification and overexpression in lung cancer development and prognosis. Cancer Res 2003 63 : 7113 7121.